Favorable remission control by allogeneic stem cell transplantation in NPM1 positive intermediate-risk AML: Donor versus no-donor analysis of 302 patients from the SAL AML-2003 trial

被引:0
|
作者
Roellig, C. [1 ]
Bornhaeuser, M. [1 ]
Thiede, C. [1 ]
Kramer, M. [1 ]
Ho, A. [2 ]
Schaefer-Eckart, K. [3 ]
Haenel, M. [4 ]
Einsele, H. [5 ]
Aulitzy, W. [6 ]
Berdel, W. E. [7 ]
Stelies, M. [7 ]
Baldus, C. [8 ]
Krause, S. W. [9 ]
Platzbecker, U. [1 ]
Schaich, M. [1 ]
Schetelig, J. [1 ]
Ehninger, G. [1 ]
机构
[1] Univ Klinikum Dresden, Med Klin & Poliklin 1, Dresden, Germany
[2] Univ Klinikum Heidelberg, Med Klin 5, Heidelberg, Germany
[3] Klinikum Nurnberg, Med Klin 5, Nurnberg, Germany
[4] Klinikum Chemnitz, Innere Med Klin 3, Chemnitz, Germany
[5] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany
[6] Robert Bosch Krankenhaus, Abt Hamatol Onkol & Palliat Med, Stuttgart, Germany
[7] Univ Klinikum Munster, Med Klin & Poliklin A, Munster, Germany
[8] Charite Campus Benjamin Franklin, Med Klin Schwerpunkt Hamatol Onkol, Berlin, Germany
[9] Univ Klinikum Erlangen, Med Klin 5, Erlangen, Germany
来源
ONKOLOGIE | 2012年 / 35卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:168 / 169
页数:2
相关论文
共 35 条
  • [1] Allogeneic Stem Cell Transplantation Confers a Favorable Outcome in Patients with NPM1 Positive Acute Myeloid Leukemia: Results From a Donor Vs. No-Donor Analysis of 309 Patients Treated in the SAL AML-2003 Trial
    Roellig, Christoph
    Bornhaeuser, Martin
    Thiede, Christian
    Kramer, Michael
    Ho, Anthony
    Wandt, Hannes
    Haenel, Mathias
    Einsele, Hermann
    Aulitzky, Walter E.
    Schmitz, Norbert
    Berdel, Wolfgang E.
    Stelljes, Matthias
    Kienast, Joachim
    Thiel, Eckhard
    Krause, Stefan W.
    Stoelzel, Friedrich
    Platzbecker, Uwe
    Schaich, Markus
    Schetelig, Johannes
    Ehninger, Gerhard
    BLOOD, 2011, 118 (21) : 230 - 230
  • [2] Allogeneic Stem-Cell Transplantation in Patients With NPM1-Mutated Acute Myeloid Leukemia: Results From a Prospective Donor Versus No-Donor Analysis of Patients After Upfront HLA Typing Within the SAL-AML 2003 Trial
    Roellig, Christoph
    Bornhaeuser, Martin
    Kramer, Michael
    Thiede, Christian
    Ho, Anthony D.
    Kraemer, Alwin
    Schaefer-Eckart, Kerstin
    Wandt, Hannes
    Haenel, Mathias
    Einsele, Hermann
    Aulitzky, Walter E.
    Schmitz, Norbert
    Berdel, Wolfgang E.
    Stelljes, Matthias
    Mueller-Tidow, Carsten
    Krug, Utz
    Platzbecker, Uwe
    Wermke, Martin
    Baldus, Claudia D.
    Krause, Stefan W.
    Stoelzel, Friedrich
    von Bonin, Malte
    Schaich, Markus
    Serve, Hubert
    Schetelig, Johannes
    Ehninger, Gerhard
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (05) : 403 - 410
  • [3] Allogeneic Stem-Cell Transplantation in Patients With NPM1-Mutated Acute Myeloid Leukemia: Results From a Prospective Donor Versus No-Donor Analysis of Patients After Upfront HLA Typing Within the SAL-AML 2003 Trial (vol 33, pg 403, 2015)
    Roellig, C.
    Bornhaeuser, M.
    Kramer, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (13) : 1519 - 1519
  • [4] ANALYSIS OF THE FLT3-ITO AND NPM1 MUTATIONS IN AML PATIENTS WITH INTERMEDIATE RISK RECEIVING ALLOGENEIC STEM-CELL TRANSPLANTATION
    Ogasawara, M.
    Yamakawa, T.
    Katsura, Y.
    Shima, K.
    Matsukawa, T.
    Kanaya, M.
    Minauchi, K.
    Nakata, M.
    Ota, S.
    Imai, K.
    Hirano, T.
    Kobayashi, N.
    Kiyama, Y.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S297 - S297
  • [5] Comparison of autologous stem cell transplantation versus haploidentical donor stem cell transplantation for favorable- and intermediate-risk acute myeloid leukemia patients in first complete remission
    Chen, Jia
    Yang, Lingyi
    Fan, Yi
    Xu, Yang
    Han, Yue
    Tang, Xiaowen
    Qiu, Huiying
    Fu, Chengcheng
    Miao, Miao
    Chen, Feng
    Wu, Depei
    BONE MARROW TRANSPLANTATION, 2018, 53 : 156 - 157
  • [6] Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission
    Chen, Jia
    Yang, Lingyi
    Fan, Yi
    Xu, Yang
    Han, Yue
    Tang, Xiaowen
    Qiu, Huiying
    Fu, Chengcheng
    Miao, Miao
    Chen, Feng
    Wu, Depei
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 779 - 788
  • [7] Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial
    J Schetelig
    M Schaich
    K Schäfer-Eckart
    M Hänel
    W E Aulitzky
    H Einsele
    N Schmitz
    W Rösler
    M Stelljes
    C D Baldus
    A D Ho
    A Neubauer
    H Serve
    J Mayer
    W E Berdel
    B Mohr
    U Oelschlägel
    S Parmentier
    C Röllig
    M Kramer
    U Platzbecker
    T Illmer
    C Thiede
    M Bornhäuser
    G Ehninger
    Leukemia, 2015, 29 : 1060 - 1068
  • [8] Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial
    Schetelig, J.
    Schaich, M.
    Schaefer-Eckart, K.
    Haenel, M.
    Aulitzky, W. E.
    Einsele, H.
    Schmitz, N.
    Roesler, W.
    Stelljes, M.
    Baldus, C. D.
    Ho, A. D.
    Neubauer, A.
    Serve, H.
    Mayer, J.
    Berdel, W. E.
    Mohr, B.
    Oelschlaegel, U.
    Parmentier, S.
    Roellig, C.
    Kramer, M.
    Platzbecker, U.
    Illmer, T.
    Thiede, C.
    Bornhaeuser, M.
    Ehninger, G.
    LEUKEMIA, 2015, 29 (05) : 1060 - 1068
  • [9] Comparison of Autologous Stem Cell Transplantation Versus Haplo-Identical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission
    Chen, Jia
    Yang, Lingyi
    Fan, Yi
    Wang, Xiuli
    Xu, Yang
    Chen, Feng
    Wang, Ying
    Zhang, Xiang
    Song, Tiemei
    Chen, Su-Ning
    Wu, Depei
    BLOOD, 2017, 130
  • [10] Favourable outcome of allogeneic stem cell transplantation for patients with intermediate-risk AML in 1.CR - A single-centre experience from 2003-2008
    Karas, M.
    Steinerova, K.
    Jindra, P.
    Lysak, D.
    Vokurka, S.
    Svoboda, T.
    Mohammad, L.
    Koza, V.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S95 - S95